In the MACC1-DBC1 pair, CRC patients with high expression of both genes had a worse outcome than those with low expression of both genes, indicating the tumor promoting role of the DBC1-MACC1 axis in CRC progression. This evidence concerns the gene CCAR2 and colorectal carcinoma.